Virus-fighting antibodies linger on in NZ Covid-19 patients
13 Jan, 2021 01:39 AM
4 minutes to read
The Moderna jab mRNA-1273 is a messenger RNA vaccine which works by instructing the body s cells to build the coronavirus spike protein . Video / AP
The Moderna jab mRNA-1273 is a messenger RNA vaccine which works by instructing the body s cells to build the coronavirus spike protein . Video / AP
Virus-fighting antibodies have been found in Kiwi Covid-19 patients up to eight months after they were infected - findings that could bode well for the coming vaccine roll-out.
The new research, released ahead of peer-review, could also prove important globally, given the antibodies persisted even when there was no virus circulating in the community.